Accessibility Menu
 
Burzynski Research Institute logo

Burzynski Research Institute

(OTC) BZYR

Current Price$0.02
Market Cap$2.15M
Since IPO (1990)-46%
5 Year-44%
1 Year-70%
1 Month-19%

Burzynski Research Institute Financials at a Glance

Market Cap

$2.15M

Revenue (TTM)

$0.00

Net Income (TTM)

$1.29M

EPS (TTM)

$-0.01

P/E Ratio

-1.67

Dividend

$0.00

Beta (Volatility)

-0.05 (Low)

Price

$0.02

Volume

24,500

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.01 - $0.06

BZYR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Burzynski Research Institute

Industry

Biotechnology

CEO

Stanislaw R. Burzynski, MD, PhD

Headquarters

Houston, TX 77055, US

BZYR Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

19%

Return on Assets

-568%

Earnings Yield

-59.88%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.15M

Shares Outstanding

131.45M

Volume

24.50K

Avg. Volume

3.95K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$1.39M

EBITDA

$1.39M

Operating Cash Flow

$388.53K

Capital Expenditure

$0.00

Free Cash Flow

$388.53K

Cash & ST Invst.

$847.00

Total Debt

$0.00

Burzynski Research Institute Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$2.15M

N/A

Market Cap/Employee

$2.15M

N/A

Employees

1

N/A

Net Income

$328.86K

+6.6%

EBITDA

$328.86K

+6.6%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Net Cash

$2.17K

+253.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-568.20%

N/A

Return on Invested Capital

19.11%

N/A

Free Cash Flow

$823.11K

-513.7%

Operating Cash Flow

$823.11K

-513.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BVAXFBioVaxys Technology Corp.
$0.05-3.60%
BIXTBioxytran, Inc.
$0.03-7.98%
THERTheralink Technologies, Inc.
$0.00+0.00%
CPMVMosaic ImmunoEngineering Inc.
$0.75+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
AAPLApple
$280.14+0.03%

Questions About BZYR

What is the current price of Burzynski Research Institute?

Burzynski Research Institute is trading at $0.02 per share.

What is the 52-week range for Burzynski Research Institute?

Over the past 52 weeks, Burzynski Research Institute has traded between $0.01 and $0.06.

How much debt does Burzynski Research Institute have?

As of the most recent reporting period, Burzynski Research Institute reported total debt of N/A.

How much cash does Burzynski Research Institute have on hand?

Burzynski Research Institute reported $2,165 in cash and cash equivalents in its most recent financial results.

What is Burzynski Research Institute’s dividend yield?

Burzynski Research Institute does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.